Although HQ was found to activate oncogenic Src linked to the upregulation of hemeoxygenase-1, an anti-oxidative protein [27], this compound rather induced cancer cell death alone and synergistically with other anti-cancer agents and also suppressed angiogenesis. Here, HMOX1 is linked to cancer.